Mild cognitive impairment in Parkinson's disease.

作者: I. Litvan , Jennifer G Goldman

DOI:

关键词:

摘要: While Parkinson’s disease (PD) traditionally has been defined by its characteristic motor hallmarks, non-motor features such as cognitive impairment and dementia are increasingly recognized part of PD. Mild is common in non-demented PD patients, occurring about 20-50%. Frequency estimates clinical mild (PD-MCI), however, vary across studies due to methodological differences lack uniform diagnostic criteria for PD-MCI. Overall, PD-MCI patients exhibit nonamnestic deficits domains executive function, attention, visuospatial function; the phenotype heterogeneous with some demonstrating greater amnestic deficits. particularly those posterior cortical profiles, may be at high risk developing dementia. Various biomarkers studied including cerebrospinal fluid, genetic analyses, neuroimaging suggest that there distinct profiles. Future using incorporating longitudinal follow-up cohorts needed understand a transitional state between normal cognition

参考文章(95)
William C Culbertson, Paul J Moberg, Daniel Weintraub, John E Duda, Matthew B Stern, Evidence for impaired encoding and retrieval memory profiles in Parkinson disease. Cognitive and Behavioral Neurology. ,vol. 17, pp. 195- 200 ,(2004)
Petri M. Mattila, Matias Röyttä, Pirkko Lönnberg, Päivi Marjamäki, Hans Helenius, Juha O. Rinne, Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment Acta Neuropathologica. ,vol. 102, pp. 160- 166 ,(2001) , 10.1007/S004010100372
E. R. Dorsey, R. Constantinescu, J. P. Thompson, K. M. Biglan, R. G. Holloway, K. Kieburtz, F. J. Marshall, B. M. Ravina, G. Schifitto, A. Siderowf, C. M. Tanner, Projected number of people with parkinson disease in the most populous nations, 2005 through 2030 Neurology. ,vol. 68, pp. 384- 386 ,(2007) , 10.1212/01.WNL.0000247740.47667.03
Ann B. Sollinger, Felicia C. Goldstein, James J. Lah, Allan I. Levey, Stewart A. Factor, Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics. Parkinsonism & Related Disorders. ,vol. 16, pp. 177- 180 ,(2010) , 10.1016/J.PARKRELDIS.2009.11.002
H. Braak, U. Rub, E.N.H. Jansen Steur, K. Del Tredici, R. A.I. de Vos, Cognitive status correlates with neuropathologic stage in Parkinson disease Neurology. ,vol. 64, pp. 1404- 1410 ,(2005) , 10.1212/01.WNL.0000158422.41380.82
A. Siderowf, S. X. Xie, H. Hurtig, D. Weintraub, J. Duda, A. Chen-Plotkin, L. M. Shaw, V. Van Deerlin, J. Q. Trojanowski, C. Clark, CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease Neurology. ,vol. 75, pp. 1055- 1061 ,(2010) , 10.1212/WNL.0B013E3181F39A78
Dag Aarsland, Kjeld Andersen, Jan P. Larsen, Anette Lolk, Prevalence and Characteristics of Dementia in Parkinson Disease Archives of Neurology. ,vol. 60, pp. 387- 392 ,(2003) , 10.1001/ARCHNEUR.60.3.387
Ronald C. Petersen, Rosebud O. Roberts, David S. Knopman, Bradley F. Boeve, Yonas E. Geda, Robert J. Ivnik, Glenn E. Smith, Clifford R. Jack, Mild cognitive impairment: ten years later. JAMA Neurology. ,vol. 66, pp. 1447- 1455 ,(2009) , 10.1001/ARCHNEUROL.2009.266
J. L. Cummings, A. Darkins, M. Mendez, M. A. Hill, D. F. Benson, Alzheimer's disease and Parkinson's disease: Comparison of speech and language alterations Neurology. ,vol. 38, pp. 680- 680 ,(1988) , 10.1212/WNL.38.5.680
P. Tiraboschi, L. A. Hansen, M. Alford, M. N. Sabbagh, B. Schoos, E. Masliah, L. J. Thal, J. Corey-Bloom, Cholinergic dysfunction in diseases with Lewy bodies. Neurology. ,vol. 54, pp. 407- 407 ,(2000) , 10.1212/WNL.54.2.407